Press Releases

eClinical Solutions’ Clinical Data Management Leaders to Co-Chair and Present at Society of Clinical Data Management (SCDM) 2020 Virtual Conference

Industry leaders to discuss the journey from data management to data sciences, present case studies on how technology platforms are automating and improving data review and reconciliation at world’s largest clinical data management conference

Lifeasible Offers Customized One-stop Service for Seed Testing

Creative Biostructure Released Fluorescence Resonance Energy Transfer (FRET) Assay

Matexcel Updated Its Bioglass Products Recently

Creative BioMart Provides a Complete Set of Protein Engineering Services

Alfa Chemistry—a Trust-Worthy Supplier of Analytical Chemistry Reagents

Alfa Chemistry announced to provide varieties of analytical chemical reagents, which could be widely used in multiple applications, such as chromatography, spectroscopy, titration (including Karl Fischer titration, acid-base titration, etc.), food microbiology, microscopy, water quality analysis, gravimetry and other analytical applications.

CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management

CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, today announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management. Summit will support the company’s continued growth and global expansion to meet accelerating customer demand worldwide.

Atorus Research Announces Release of Second R Package

Atorus Research, a clinical analytics company that builds tools and solutions that efficiently facilitate data management and biometric activities, is pleased to announce the release of their second R package, Tplyr.

Patients Receive New Potential Treatment for Severe Pneumonia Associated with COVID-19

BioAegis partners with EastHORN Clinical Services on COVID-19 Program

ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19

ANA Therapeutics and Quotient Sciences today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19. As part of the collaboration, Quotient will scale up the capsule formulation, characterize and optimize the manufacturing process and ensure continuity of drug product through clinical trials.

Creative Biolabs’ Oncolytic Virus Construction Services Help to Shape the Future of Oncolytic Virotherapy

As a novel strategy for treatment of tumors, oncolytic virotherapy attracts many attention from global researchers. As a world-leading expert in the field of oncolytic virus, Creative Biolabs has executed every strategy to optimize its virus construction services.

THREAD Accelerates Expansion to Advance Global Decentralized Clinical Trials

Innovative Technology and Service Provider Receives Additional $50 Million Capital Commitment from Water Street and JLL Partners

Bioactive Matrixes Products Covering the Full Range Are Now Available at CD Bioparticles

As an established drug delivery company focusing on the development and production of drug delivery systems, CD Bioparticles has released a variety of bioactive matrixes covering reagents&assays, responsive hydrogels, functional biomatrixes and photocrosslinkable kits.

BioIVT Offers Expedited Delivery of Immune Cell Products for Cell and Gene Therapy Research, Drug Discovery and Diagnostic Development

BioIVT now provides same-day or next-day global delivery of fresh blood and immune cell products from its seven blood donor centers located in the US and UK.

Chemical Drug Development Service Now Available at AI & Medicine

As an expert in AI-assisted drug discovery, AI & Medicine recently announces to provide chemical drug development service for researchers worldwide. The powerful AI-assisted drug discovery platform independently developed by this company has already been adopted by a few pharmaceutical companies in their drug R&D endeavors of innovative therapies.

Alfa Chemistry Catalysts—an Expert in Catalysts Science

To better meet the ever-increasing demand for catalysts in the market, Alfa Chemistry Catalysts is founded and specialized in providing various categories of catalysts, including chiral catalysts, ligands, metal catalysts, non-metal catalysts, organocatalysts, phase transfer catalysts, photocatalysts, and reaction type.

Latest Updates: CAR Design and Construction Services Are Optimized at Creative Biolabs

Based on the leading CellRapeuticsTM CAR technology platform, Creative Biolabs has optimized the CAR design and construction services, especially for CAR-T therapy and CAR-NK therapy.

Creative Diagnostics Offers High-quality Magnetic Silica Particles for DNA & RNA Isolation

Creative Diagnostics has released high-quality magnetic silica particles for the isolation of nucleic acid (DNA, RNA) as well as large versus small fragments from various kinds of body fluids, which just takes 3 seconds for complete separation.

Noxopharm Announces New Research Showing Veyonda® Cancer Survival Rates

Australian clinical-stage drug development company Noxopharm is pleased to announce peer-reviewed publication of research showing that in late-stage prostate cancer patients who have exhausted all standard treatment options, a combination of 177Lu-PSMA-617 and Veyonda® is both safe and delivered promising efficacy outcomes, among them a median overall survival of 17.1 months.

BOC Sciences Released A New Antibody-drug Conjugate Technology Platform